Can Akpınaroğlu
banner
canakpinaroglu.bsky.social
Can Akpınaroğlu
@canakpinaroglu.bsky.social
Postgraduate Associate @YaleMed
Molecular medicine • Oncology • Proteomics
Exploring cancer biology at the systems level 🧬
Science communicator & lifelong learner 🧪
Passionate about medicine, omics integration, and translational research 🔬
🩵🧪🎨
October 29, 2025 at 3:00 PM
This is what YPGA is about: visibility, diversity, and collaboration across disciplines.

✨️ Already excited for next year. If you’re interested in getting involved, check our webpages:

yaleconnect.yale.edu/ypga/home/
www.instagram.com/yalepga/
September 20, 2025 at 4:20 PM
⚕️ Huge thanks to our keynote Dr. Lindsay McAlpine for an inspiring talk on Long COVID & neuroimmunology, and to our career & MD/PhD panelists for real, generous advice. Most of all, shout-out to every postgrad who asked bold questions, presented beautiful posters, and made new connections.
September 20, 2025 at 4:20 PM
🏛 As YPGA Vice President - Public Relations, and a proud member of the committee, it was extra special to help host; and to present my own poster on "Sex Specific Effects of Asparagine in Colorectal Cancer". 🧪
September 20, 2025 at 4:20 PM
I’m grateful, focused, & will continue to keep moving forward🌟
Follow me for future protocol tips, data peeks, and the occasional science memes from the front lines of research, as I continue sharing on the social media corner of academia.
🧭 linktr.ee/Can.Akpinaro...
June 30, 2025 at 9:35 PM
Despite the ongoing and severe NIH funding cuts impacting researchers nationwide, this opportunity reminds me that diligence, adaptability, and perseverance can still carry us through during difficult times. Circumstances may test us very harshly, but those who keep building, can survive & thrive🐦‍🔥
June 30, 2025 at 9:35 PM
We’re exploring how metabolic differences drive sex/race-specific vulnerabilities in colorectal cancer.
And why would this matter? 🔬

• Tumor metabolism is a moving target, metabolomics could be a pressure point
• Sex & race-based differences remain under-investigated. We aim to change that.
June 30, 2025 at 9:35 PM
Dr. Khan’s lab leads cutting-edge research at the intersection of oncology, surgery, and translational science, and I’m excited to contribute to a team that’s both clinically grounded and innovation-driven. 🥼

(Photo by Thomas Breen, New Haven Independent)
June 30, 2025 at 9:35 PM
We explored buffer formulation, protein denaturation, reduction & alkylation chemistry, and precipitation strategies, showing how small tweaks can boost peptide recovery and robustness.

Grateful for the chance to share & learn! 💖
🧠 Let’s connect: linktr.ee/Can.Akpinaro...
Can Akpınaroğlu | Linktree
Advancing research discoveries in cancer biology & molecular medicine at Yale 🧬
linktr.ee
May 7, 2025 at 9:30 PM
I presented my work on optimizing core techniques and workflows for DIA-MS proteomics sample prep. From phospho/glycopeptide enrichment to in-solution/in-gel digestion, protein quantification and C18 desalting, every step counts when precision and reproducibility are the goal. 🧪
May 7, 2025 at 9:30 PM
Our lab, YSL Proteomics, was also present, showcasing our cancer research, proteomics, and lipidomics driven by mass spectrometry. 🧪
I had the incredible opportunity to present my poster in this annual retreat!
It was inspiring to exchange ideas with brilliant minds across Yale’s research community🫀
May 3, 2025 at 2:48 PM